Photo - Prometheus
Photo - UES
Photo - UPS

 

Our project based on early detection of congenital heart defects began its journey in 2020.

Based on our previous experience, we have been able to build a highly specialized and complementary team.

For us, early, rapid and accurate diagnosis of congenital heart defects is a problem that has not been solved to date. We are determined to change this.

Recent years of R&D work have brought results that have surpassed our expectations. We hope that as the work proceeds, we will be able to offer our technology to a wide audience, which using our tool will be able to ensure better health and even life for their patients.

products

Easy-to-use AI algorithm systems

We have developed two easy-to-use AI algorithm systems for automatically detecting CHD in defined diagnostic ultrasound recordings during routine screening examinations.

A set of algorithms designed to detect congenital heart defects in newborns, with future applications for children and adults.

more +

Cloud-based AI algorithm system that analyzes 2D fetal heart function clips recorded by any ultrasound device in a standardized way by an obstetrician between the 17th and 28th week of pregnancy.

more +
our team

High-level specialists

Prometheus is a multidisciplinary, complementary team of high-level specialists in: medicine, technology and management.

join us

Do you want to be
part
of our team?

If you have expertise in technology or medicine and want to make a real difference, contact us!

More information

Pawel Kusmierowski

Master of Engineering and IESE Business School executive education program alumni. A seasoned executive with a background as a former board member at prominent life sciences and healthcare companies in Poland, including Neuca and PZU Zdrowie. Bringing international expertise in M&A, business development and consulting, recently served as a dedicated industry partner at Deloitte Digital.

Przemysław Henschke

Przemek Henschke brings years of experience in building high-performing teams and technology solutions, managing complex projects, and leading IT operations within financial institutions. He has a strong track record in shaping and executing IT and enterprise-wide strategies.

He has served as CIO at several major financial organizations in Poland, including Inteligo, Lukas Bank, Polbank EFG, ING, and PZU. He played a foundational role in the launch and development of Inteligo and Polbank, and more recently contributed to the creation of Bank D360 in Saudi Arabia.

Przemek also worked at McKinsey & Company, where he advised some of the largest financial institutions across Europe and the Middle East.

Tomasz Bartosiak

Has over 12 years of experience in marketing, working with pharmaceutical and FMCG corporations such as Adamed, Aflofarm, KRKA, and RECKITT BENCKISER. He is also a member of the Supervisory Board of Medical Clinic Remedium. With experience in the public and private sectors.

Wiktor Strzelczyk

Experienced sales strategist with expertise in the medical and insurance industries. He has worked at companies such as Bor-Pol, Exemed, BellyOn, and Grupa MAK-STBU. He has a proven track record of success in implementing innovative medical solutions and is a licensed insurance broker.

Professor Przemysław Oszukowski

Full Professor at the Medical University of Łódź and serves as the Head of the Department of Obstetrics and Perinatology at the same institution. Additionally, hecurrently holds the position of Head of the Delivery Room at the Institute of Centrum Zdrowia Matki Polki.

Professor Marcin Wiecheć

Jagiellonian University. Member of the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), involved in developing global guidelines, and recognized by TIME magazine for his original solution Fetal Heart VR.

Professor Robert Sabiniewicz

Head of the Department and Clinics of Pediatric Cardiology and Congenital Heart Defects at the Medical University of Gdańsk. He mainly deals with minimally invasive, percutaneous techniques for the treatment of heart defects. He is an expert in the implementation of these technologies.

our mission

We believe that the development of AI-based technology can bring a radical change in the rapid and accurate diagnosis of congenital heart defects. We want to be part of a huge change that will help specialists and patients themselves in the battle for a healthier tomorrow.

  • Develop Cutting-Edge Diagnostic Technologies:
    Innovate and enhance non-invasive AI diagnostic tools to detect fetal congenital heart defects early and accurately.
  • Expand Accessibility and Reach:
    Increase the availability of advanced prenatal diagnostic tools to a wider population, ensuring that expectant parents globally have access to superior diagnostics.
  • Ensure High Standards of Quality and Efficiency:
    Maintain and continuously improve the quality and speed of diagnostic services, providing reliable and timely results to healthcare providers and parents.
  • Collaborate with Medical Professionals and Institutions:
    Foster partnerships with universities, research institutes, hospitals, clinics, and medical professionals to integrate advanced diagnostic tools into standard prenatal care practices.
  • Educate and Support (Future) Parents:
    Provide comprehensive education and support resources to future parents, helping them understand the importance of early detection and the benefits of non-invasive diagnostic technologies.
news/information

Stay tuned, follow the latest news

Photo - International Expansion of Ultra Echo Scan Supported by EU Funding

International Expansion of Ultra Echo Scan Supported by EU Funding

We are proud to announce that UES Sp. z o.o. has received European Union funding to support the international expansion of our…

more +
Photo - Prometheus MedTech.AI Recognized Among Top 10 Health Startups at South Summit Madrid 2025

Prometheus MedTech.AI Recognized Among Top 10 Health Startups at South Summit Madrid 2025

We are thrilled to announce that Prometheus MedTech.AI has been selected as one of the Top 10 startups in the Health category at South Summit…

more +
Photo - Prometheus MedTech.AI at Wolves Summit 2025: Driving MedTech Innovation from Hospital Partnerships

Prometheus MedTech.AI at Wolves Summit 2025: Driving MedTech Innovation from Hospital Partnerships

Prometheus MedTech.AI was proud to participate in Wolves Summit 2025, one of Central and Eastern Europe’s leading events focused on…

more +
Photo - Prometheus MedTech.AI Secures Deeptech Funding for AI-Based Cardiology Project

Prometheus MedTech.AI Secures Deeptech Funding for AI-Based Cardiology Project

We’re pleased to announce that Prometheus MedTech.AI (LPTW Sp. z o.o.) has been awarded a grant of 400,000 PLN as part…

more +
Photo - Today, Prometheus Med Tech.AI is live from Palo Alto

Today, Prometheus Med Tech.AI is live from Palo Alto

We’re presenting at the “Revolutionizing Healthcare: AI, Technology and Impact” conference, showcasing Prometheus Med Tech.AI – our advanced platform designed…

more +
Photo - Prometheus Med Tech.AI at MCSC Hospital Leadership Innovation Impact Day 2025!

Prometheus Med Tech.AI at MCSC Hospital Leadership Innovation Impact Day 2025!

We had the pleasure of participating in an event that attracted tremendous interest from the medical community and health tech…

more +
our partners

We appreciate the trust and commitment of our industry partners and funds, which enable Prometheus to carry out its mission with increasing momentum.

Partner Logo
Partner Logo
Partner Logo
Partner Logo
Partner Logo
Partner Logo
Partner Logo
Partner Logo
Partner Logo
Partner Logo
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.